資源の限られた環境における門診の親腸内抗菌薬療法の有効性,安全性,実行可能性:試験的な長期研究
Amit Kumar1, Prasan Kumar Panda2
1Department of Medicine, All India Institute of Medical Sciences, Rishikesh 249203, Uttarakhand, India.
World journal of methodology
|September 3, 2025
まとめ
外来親腸内抗菌薬療法 (OPAT) は,資源が乏しい環境では安全で有効であり,入院期間を2週間短縮します. このアプローチは,抗菌剤の管理を大きく支援し,抗菌剤耐性 (AMR) と闘います.
科学分野:
- 感染症
- 公衆衛生
- 抗菌管理について
背景:
- 外来親腸内抗菌剤療法 (OPAT) は,病院外での抗菌剤の静脈内/筋肉内投与を安全に可能にし,合併症や入院期間を減少させます.
- OPATは重要な抗菌管理介入で 経済的・物流上の利点があります
- 証拠に基づいたOPATの実践は インドのような資源の限られた環境では十分に活用されていない.
研究 の 目的:
- 資源不足の環境におけるOPATの有効性,安全性,実行可能性を評価する.
- OPATの実施のための障壁とファシリテーターを特定する.
- 抗菌管理におけるOPATの役割を評価する.
主な方法:
- OPATの基準を満たす患者の試験的な長期観察試験.
- 退院前の教育,カウンセリング,人口統計データ収集
- 文献のレビュー,魚骨図,患者のフィードバック,医療従事者のインタビュー
主要な成果:
- 20人の患者が含まれ,19人が無熱状態に達した.
- OPATは,自宅 (15) または介護施設 (5) で,家族 (9) または看護師 (11) の介護で投与されます.
- 平均 2 週間の入院削減; 医師は利点に気づきましたが,標準化とリソースの課題を挙げました.
結論:
- OPATは安全で実行可能で 資源が乏しい環境では 病院での入院を2週間短縮します
- OPATは,入院と関連する合併症を最小限に抑えることで,抗菌薬の管理を直接サポートします.
- このアプローチは抗菌剤耐性 (AMR) と戦うために不可欠であり,世界的なAMR行動計画と一致しています.
さらに関連する動画
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
14.8K
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.8K
関連する概念動画
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
39
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
39
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
300
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
300
01:25Routes of Drug Administration: Parenteral
2.1K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.1K
01:28Antimicrobial Effectiveness
156
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
156
01:28Pneumonia IV: Management
445
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
445
01:29Drug Delivery: Parenteral Route
827
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
827